For information on the K-PAX Canadian Study (The MAINTAIN Study), which is currently enrolling patients, please click here.

K-PAX Immune Support Formula was the micronutrient formula tested in a double-blinded, placebo-controlled clinical trial which demonstrated a positive effect on the immune systems of HIV(+) individuals on antiviral therapy.

Forty HIV-infected patients taking a stable antiviral medication regimen were randomized to either the K-PAX formula or placebo groups. After 12 weeks, the patients taking the K-PAX formula experienced an average 24% increase in their CD4 count compared to no change in the placebo group (P=0.01).

The mean absolute CD4 count also rose significantly by an average of 65 cells after 12 weeks in the micronutrient group versus a 6 cell decline in the placebo group (P=0.029).

This research study was presented at the 2006 World AIDS Conference in Toronto (Abstract #0402). It was also published in the August 15th issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS) - Kaiser JD, et al. JAIDS 2006;42(5):523-528.

For additional information about this research study please email us at: ask@KPAXpharm.com

K-PAX is a dietary supplement and is not indicated for the diagnosis, prevention, or treatment of any medical condition. Individual results may vary.